Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an
achievable goal for most patients. Reaching this target leads to improved outcomes. The …

Methods: Admission and rotavirus identification data from the major pediatric hospitals in 3
states (2 using RV5, 1 RV1), together with state-based hospitalization and vaccination data …

Objective To describe the clinical features and course of a cohort of patients with juvenile
dermatomyositis ( JDM ) at a tertiary referral pediatric centre in A ustralia and examine changes …

Objective. The main objective was to determine the 2-year clinical benefit and safety of
etanercept (ETN) in children with the juvenile idiopathic arthritis (JIA) categories of extended …

High-dose intravenous pulse methylprednisolone is an important therapeutic modality for
many autoimmune conditions in both children and adults. Adverse effects of this therapy …

Objective Sjögren syndrome in children is a poorly understood autoimmune disease. We
aimed to describe the clinical and diagnostic features of children diagnosed with Sjögren …

Purpose To collect retrospective data of patients with Juvenile Idiopathic Arthritis (JIA) and
other rheumatic diseases who received live attenuated booster measles-mumps-rubella (MMR…

Background Juvenile Idiopathic Arthritis (JIA) is a complex autoimmune rheumatic disease
of largely unknown cause. Evidence is growing that epigenetic variation, particularly DNA …

Background The aetiology of juvenile idiopathic arthritis (JIA) is largely unknown. We have
established a JIA biobank in Melbourne, Australia called CLARITY – C hiL dhood A rthritis R …

Sweet’s syndrome (SS) is an uncommon condition characterized by recurrent painful cutaneous
inflammatory eruptions. It is rare in childhood and has a broad range of extracutaneous …